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Producing soluble proteins in Escherichia coli is still a major
bottleneck for structural proteomics. Therefore, screening for
soluble expression on a small scale is an attractive way of
identifying constructs that are likely to be amenable to
structural analysis. A variety of expression-screening methods
have been developed within the Structural Proteomics In
Europe (SPINE) consortium and to assist the further
refinement of such approaches, eight laboratories partici-
pating in the network have benchmarked their protocols. For
this study, the solubility profiles of a common set of 96 His6-
tagged proteins were assessed by expression screening in
E. coli. The level of soluble expression for each target was
scored according to estimated protein yield. By reference to a
subset of the proteins, it is demonstrated that the small-scale
result can provide a useful indicator of the amount of soluble
protein likely to be produced on a large scale (i.e. sufficient for
structural studies). In general, there was agreement between
the different groups as to which targets were not soluble and
which were the most soluble. However, for a large number of
the targets there were wide discrepancies in the results
reported from the different screening methods, which is
correlated with variations in the procedures and the range of
parameters explored. Given finite resources, it appears that
the question of how to most effectively explore ‘expression
space’ is similar to several other multi-parameter problems
faced by crystallographers, such as crystallization.
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1. Introduction
Small-scale screening for soluble expression in Escherichia
coli is a key feature of the experimental pipelines that have
been implemented for structural proteomics projects in a
number of European laboratories (Alzari et al., 2006). The
justification for such screening is that it provides information
to guide subsequent decisions on whether to invest in large-
scale purification of a given construct. Reducing the time,
effort and cost of each expression trial should enable more
constructs to be tested and expression parameters to be
optimized (Folkers et al., 2004 and references therein).
However, screening methods are only of value if they satisfy
two fundamental criteria. Firstly, they must be reproducible
and secondly, they must give reliable qualitative and ideally
quantitative predictions of the outcome of the larger scale
protein production needed to produce sufficient protein for
structural studies. The central question is therefore ‘how
should we configure small-scale expression screening in order
to establish a route to the production of milligram amounts of
soluble protein on scale-up?’ To this end, we have compared
the methods routinely used in eight different laboratories in
the SPINE consortium (Berlin, Marseille, Orsay, Oxford,
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Table 1
Variable parameters at key stages of the expression screen process by centre.
Parameter Berlin Marseille Orsay Oxford Stockholm Strasbourg Utrecht Weizmann
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Stockholm, Strasbourg, Utrecht and the Weizmann) for
soluble expression screening in E. coli using a common set of
96 expression vectors. These encode proteins ranging in
molecular weight from 9 kDa to more than 100 kDa (see
supplementary material1) and were largely eukaryotic or viral
in origin. The parameters varied included E. coli strain, growth
temperature, optical density at induction, culture-vessel size
and design, agitation levels, media and lysis method. We
present simple statistical analyses of the results obtained in a
single representative screening experiment performed by each
centre and suggest guidelines for the future refinement of such
protocols.
2. Materials and methods
General methods are described below and specific features or
variants of the methodologies for the different laboratories
are specified in Table 1.
2.1. Target vectors
The test set of 96 expression constructs was assembled from
seven of the eight SPINE groups that participated in the study,
with each group contributing between eight and 16 plasmids
(as mini-preparations). The large majority of these targeted
human or viral proteins. The choice of targets was not
constrained and only the vector details, molecular weight and
other biophysical properties expected of the expressed
products (including fusion partners) were submitted (see
supplementary material). It is clear from the results that the
panel of targets contained a significant number of plasmids
that had failed to yield soluble protein in-house and the set is
therefore representative of ‘difficult’ targets. All plasmids used
the T7 promoter system for transcriptional regulation in
combination with E. coli strains harbouring the DE3 prophage
(Studier et al., 1990). In addition, all constructs encoded a His6
tag fused to the protein of interest to enable routine purifi-
cation using immobilized metal-chelating resin (see supple-
mentary material). The constructs were transformed (at a
single site, Oxford) in parallel into Omnimax bacteriophage-
resistant competent cells in 96-well format (Invitrogen,
Paisley, Scotland) for plasmid propagation. After culturing in
96-well blocks, the plasmids were prepared on a Biorobot 8000
using the 96 Turbo Miniprep kit (Qiagen, West Sussex,
England). These plasmid preparations, of a standard concen-
tration and quality, were then distributed in 96-well format to
the participating SPINE centres for use in expression screen
trials.
2.2. Expression protocol
2.2.1. Host strains. One or more E. coli strains drawn from
a panel comprising the lon and ompT protease-deficient BL21
(DE3) and derivatives [including Rosetta (DE3) and
RosettaII (DE3), B834 (DE3), BL21-Gold (DE3) and BL21-
AI] were used by each of the laboratories. The Rosetta
(Merck) strains carry a chloramphenicol-resistant plasmid,
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Table 1 (continued)





































































































































































1 Supplementary material has been deposited in the IUCr electronic archive
(Reference: GX5098). Services for accessing this material are detailed at the
back of the journal.
pRARE, that contributes tRNAs for codons rarely used in E.
coli. LysS and LysE variants of the pRARE plasmid consti-
tutively express T7 lysozyme, a natural inhibitor of T7 RNA
polymerase activity, reducing polymerase activity in unin-
duced cells. The B834 (DE3) strain (Merck) is the methionine-
auxotrophic version of BL21 (DE3), which allows efficient
selenomethionine labelling of expressed proteins
(Hendrickson et al., 1990). The BL21-Gold (DE3) strain
(Stratagene, La Jolla, CA, USA) has been developed to
increase transformation efficiency and is recA-deficient to
improve the stability of expression vectors. BL21-AI (Invi-
trogen, Carlsbad, CA, USA) carries a chromosomal copy of
the T7 RNA polymerase gene under the control of the
arabinose-inducible araBAD promoter conferring low basal
expression prior to induction and dose-dependent induction.
Finally, C41 (DE3) (Avidis, St Beauzire, France) is a mutant
that allows overexpression of proteins that are toxic to the
BL21 (DE3) parental strain (Dumon-Seignovert et al., 2004).
In this study, the LysS variant of the pRARE plasmid was
transformed into the C41 (DE3) strain by Marseille. The only
non-BL21 (DE3) derived strain used was the K-12 based
Origami strain (Merck) which carries mutations in both the
thioredoxin reductase (trxB) and the glutathione reductase
(gor) genes, which enhance disulfide-bond formation in the
cytoplasm of E. coli.
Competent cells of the expression strains were prepared by
each group using variations on the calcium chloride procedure
(Hanahan, 1983; Inoue et al., 1990; Nakata et al., 1997), except
for Stockholm where Z-competent cells (Zymo Research
Corporation, Orange, CA, USA) were used. Transformations
were performed in parallel in either 96-well plates or racked
tubes in 96-well format, except at the Weizmann where indi-
vidual tubes and plates were used. No major differences in
transformation efficiencies were noted between the centres in
spite of the variations between the protocols used (volume of
competent cells used, recovery volumes and plating volumes).
Typically, the transformation mix was plated out and a single
colony was picked for the starter culture prior to dilution and
regrowth for the expression-screening experiment. To test
reproducibility, the Berlin centre inoculated two pre-cultures,
each from one isolated colony, and subsequently obtained
similar expression results (data not shown). Three centres
(Marseille, Orsay and Utrecht) directly inoculated the pre-
culture from the transformation mix (to save time and
circumvent the error-prone colony-picking step) without
impairing growth or expression (data not shown).
2.2.2. Culture conditions. To reduce variations in culture
density between clones during the growth step, cultures were
inoculated from starter cultures which had reached saturation
following growth overnight at 310 K. One centre (Utrecht) did
not use a pre-culture as cultures were monitored throughout
the entire growth phase and all cultures were then induced at
identical OD. The dilution factor for inoculation (pre-culture
to expression culture) varied between laboratories. Either a
volume was added to give a specific OD at inoculation (usually
0.1 OD600nm) or a fixed dilution of the starter culture was used
(from 1/10th to 1/250th of the culture volume).
With one exception (Weizmann, where shaken 14 ml tubes
were used), cultures were performed in parallel using shaken
deep-well blocks: either four 24-deep-well blocks or a single
96-deep-well block. A variety of media were used (LB, 2YT,
TB/SB+KPB, GS96 and non-inducing ZYM-5052 and Over-
night Express Instant TB); media formulations are given in the
supplementary material). Cultures were grown at various
temperatures and shaking speeds either for a fixed time or
until a given OD600nm was obtained before induction (see
Table 1).
2.3. Protein expression/solubility analysis
The cells were harvested by centrifugation and resuspended
in an appropriate volume of lysis buffer, except in Utrecht
where PopCulture solution (Merck) was used to lyse the cells
whilst still suspended in medium. Lysis buffer composition
differed from one laboratory to another, but generally
consisted of a buffered saline solution (100–500 mM NaCl in
20–200 mM Tris–HCl or phosphates at pH 7.5 or 8) containing
additives such as -mercaptoethanol, PMSF, glycerol, DNAse
I, benzonase, lysozyme and various detergents (Table 1). Cells
were disrupted by either mechanical means (sonication by a
probe modified for plate-based sonication) or by the action of
lysozyme with or without freeze–thaw cycle(s). Five labora-
tories (Orsay, Oxford, Stockholm, Strasbourg and Weizmann)
took post-lysis samples to measure the total cell protein
content (see supplementary material). The lysate was
separated, either by centrifugation or filtration, into soluble
fractions (supernatant or filtrate) or insoluble fractions (pellet
or retentate). The remaining centres (Berlin, Marseille,
Utrecht) proceeded to the affinity mini-purification step
without clarification of the lysate.
Soluble proteins were either analysed directly by SDS–
PAGE or purified by immobilized metal-affinity chromato-
graphy (IMAC) prior to SDS–PAGE analysis. Matrix-bound
proteins were eluted by the addition of either SDS–PAGE
sample/Laemmli buffer or an elution buffer containing high
concentrations of imidazole (>200 mM). Two centres
(Marseille and Stockholm) used dot-blotting to screen for
expression/solubility and confirmed profiles by SDS–PAGE
(Vincentelli et al., 2005; Knaust & Nordlund, 2001; Cornvik et
al., 2005). Briefly, the technique consists of applying the
different fractions (total or insoluble protein, soluble protein
and histidine-chelate-purified protein) directly onto PVDF/
nitrocellulose membrane by filtration under vacuum.
Following immobilization, the membranes were thoroughly
washed and the His6-tagged proteins detected by tag-specific
antibodies.
2.4. Statistical analysis
Each group (j) scored the level of soluble expression
obtained for each target k (SOLj,k) using their standard
detection methods (SDS–PAGE and/or dot-blot) in their
routine screen according to a standardized regime (1, not
performed; 0, no detectable expression or degraded protein; 1,
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expression predicted to give less than 0.5 mg l1 at scale; 2,
0.5–5.0 mg l1; 3, >5 mg l1).
Several laboratories investigated expression under multiple
growth conditions for each target using their standard proce-
dure for small-scale expression screening and for some sites
these results were consolidated and the best-case score for
each target submitted, whereas other laboratories submitted
multiple sets of scores, each derived from an individual growth
condition, which were similarly consolidated for certain
analyses. The best-case score for target k in laboratory j,
BESTj,k, is simply the greatest value of SOLj,k. In all cases, the
scores supplied by each group came from a single screening
experiment and were not further moderated.
Scores for each target, k, were summed across laboratories










The scores were further binned in two separate ways, firstly as
to whether there was a consensus that soluble expression was
achievable even at a low level and secondly to identify those
targets where there was a consensus that soluble expression
was at a sufficient level to be useful for scale-up. The first
measure, EXPRESSIONk, was defined as positive if the
majority of groups reported scores of 1–3 for BESTj,k. The
second measure, SCALEk, was defined as positive if the
majority of groups scored BESTj,k at 2 or 3.
3. Results and discussion
3.1. Reproducibility and predictive power
To justify the value of the detailed analysis of the
comparative data which form the heart of this study, we firstly
present additional data to demonstrate that such protocols can
be both reproducible and provide reliable predictions of
soluble protein yield on scale-up.
3.1.1. Reproducibility. Evidence for the reproducibility of
small-scale screening comes from previous (unpublished)
results from Oxford where, in a separate study, 33 out of 66
constructs produced soluble protein, with 85% consistency
between two separate experiments. The Berlin group eval-
uated expression from two independent clones (see x2.2.2)
with consistent results (data not shown). To extend this to
address the question of reproducibility between different
laboratories, the results of soluble expression for the first 24
targets of the benchmark list (see supplementary material) will
be considered. The results of screening these targets by the
Utrecht, Oxford, Stockholm and Marseille groups are shown
in Fig. 1 and summarized in Table 2. The Utrecht group
observed that 14 of the first 24 targets were expressed (Fig. 1a)
and that nine of these showed soluble expression (Fig. 1b,
Table 2). The Oxford screen detected eight of these nine
proteins as soluble and gave a further three soluble hits
(targets 2, 15 and 17, Fig. 1c and Table 2). This shows that
there is consistency between the two groups using a similar
protocol, but also a difference in the overall hit rate. The
differences between the two groups are most likely to be the
result of the smaller culture volume used by the Utrecht
group, which prevented detection of the weakly expressed
clones. The results of using dot-blots to detect soluble
expression for the first 24 targets are shown in Figs. 1(d) and
1(e) and summarized in Table 2. The Stockholm group scored
seven proteins as soluble, whilst soluble expression of 12
proteins was obtained in the Marseille screen (Fig. 1e and
Table 2). However, the Marseille screen explored a much
larger range of expression conditions compared with the
Stockholm protocol (Table 1). A comparison of the results
obtained by SDS–PAGE with the dot-blot screens shows that
six of the constructs identified as soluble by SDS–PAGE also
gave visible signals in both dot-blots (Table 2). For the most
part, these were targets with the highest soluble expression
scores. Conversely, all four groups were generally in agree-
ment upon the targets which did not show any soluble
expression. Thus, it appears that the detection of targets that
are either highly soluble or insoluble is reproducible between
different groups. Variations appear for those proteins that are
only expressed with relatively limited solubility. This obser-
vation is borne out by the analysis of data on soluble
expression from all the groups (see below).
3.1.2. Predictive value of the small-scale expression screen.
For 31 of the 96 constructs in the benchmark study, the yields
of soluble protein obtained following scale-up of cultures to at
least 1 l culture volume were available. Larger scale cultures
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Table 2
The soluble expression scores assigned by the Utrecht, Oxford, Stock-
holm and Marseille groups for the each of the targets 1–24 based on the
results shown in Fig. 1.
The expected molecular weight of each of the targets is also given. A full set of
data for all targets and groups are given in the supplementary material.
Target MW (kDa) Utrecht Oxford Stockholm Marseille
1 21.75 2 1 0 3
2 15.6 0 1 0 0
3 19.45 3 3 3 3
4 12.3 3 3 3 3
5 25 0 0 0 0
6 24.9 0 0 0 0
7 10.55 2 1 3 3
8 22.4 0 0 0 3
9 11.8 0 0 0 0
10 13.9 0 0 0 0
11 13.7 3 1 0 1
12 13.6 2 0 0 1
13 22.6 2 2 3 1
14 13.15 3 3 3 3
15 34.75 2 1 2 0
16 19.9 0 0 0 0
17 12.00 0 1 0 3
18 13.60 3 2 3 3
19 30.00 0 0 0 0
20 15.70 0 0 0 0
21 9.80 0 0 0 0
22 21.30 0 0 0 0
23 11.70 0 0 0 0
24 51.90 0 0 0 1
were carried out using the culture condition identified at small
scale that gave the best soluble expression score. By
comparing these results with the level of soluble expression
estimated from the small-scale screen, some assessment of the
predictive value of screening can be made. Of the 31 targets,
only three appeared as ‘non-predictive’ outliers. Construct 1
was scored as 1 but yielded >5 mg l1 at scale, whereas
constructs 17 and 18 scored 3 but failed to produce soluble
protein on scale-up (although in these cases the scaled
expression cultures were performed in minimal media, prob-
ably accounting for the discrepancy). In general, the
comparison supports the predictive value of screening for
soluble expression on a small scale, which enables candidates
for scale-up to be ranked. For routine scale-up of E. coli
cultures, 1 l cultures are typical, particularly for producing
multiple targets in parallel for structural genomics projects.
With the advent of sub-microlitre volumes of drops for crys-
tallization screens (Sulzenbacher et al., 2002; Walter et al.,
2005), a 1 l culture can be expected to yield sufficient material
for a primary crystallization screen (which ranges from one set
of 96 conditions up to five 96-condition plates, depending upon
the centre), since with 100 nl protein drops only 150 mg of
concentrated protein (typically at 10 mg ml1) is required for
each 96-well plate of screening conditions.
The present analysis of 31 targets (which are probably
representative of relatively difficult targets) suggests that
triage on the basis of the small-scale results would dramati-
cally reduce the number of targets that progress to large-scale
culture preparations. The disadvantage of the screening
approach is the potential to ‘miss’ a small percentage of
proteins by not progressing to scale-up cultures. Nevertheless,
on the basis of these results we find the loss of a small number
of targets for scale-up is more than balanced by the increased
throughput possible with small-scale expression screening
experiments, which allows a greater range of contructs to be
explored.
3.2. Overall success levels
The results of expression analysis are detailed in the
supplementary material and summarized in Fig. 2. Overall,
detectable soluble expression (BEST > 0) was reported for 81
of the 96 targets by at least one laboratory. However, only 25
of these achieved consensus expression across the laboratories
(EXPRESSj positive), eight of which were predicted as
scaleable (SCALEj positive). There was a dramatic variation
in the number of proteins reported as expressed by the
different laboratories, ranging from 56 reported by Berlin to
17 by Strasbourg. It is perhaps not surprising that the number
from Strasbourg should be low since they were the only
laboratory to use a single procedure (Busso et al., 2005),
whereas other laboratories tested several different variables,
as discussed below. Not only was there a variation in the
overall number of targets reported as expressing, but there
was considerable variation as to which targets were successful
in each laboratory. This was reflected in the fact that pairwise
linear correlation coefficients calculated on the scores (BEST)
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Figure 1
Representative experiments of total expression (a) and soluble expres-
sion after IMAC purification (b) from Utrecht using RosettaII (DE3), as
determined by SDS–PAGE. (c) Soluble expression from Oxford after
IMAC in Rosetta (DE3)-pLysS as determined by SDS–PAGE. The first
and last lanes are molecular-weight markers. (d) Insoluble (pellet) and
soluble expression from Stockholm after IMAC in the indicated bacterial
strains BL21 (DE3) or RosettaII (DE3). Protein was detected using the
dot-blot procedure described by Knaust & Nordlund (2001). The scale on
the right is displayed as an indicator for ‘very good’, ‘good’, ‘weak’, ‘poor’
and ‘non’ expressed protein. (e) Soluble expression as determined by
Marseille using a dot-blot procedure (Vincentelli et al., 2005), where
expression was performed in parallel (1152 conditions) using three
different media (light grey, 2YT; dark grey, SB; black, TB), three different
culture temperatures (290, 298 and 310 K) and four different bacterial
strains [B = BL21 (DE3)-pLysS, R = Rosetta (DE3)-pLysS, O = Origami
(DE3)-pLysS, C = C41 (DE3)-pLysSRARE]. 12 out of the 36 possible
conditions were used in an incomplete factorial approach as schematically
indicated in the shaded table [e.g. the first spot of every expression test
refers to an experiment performed at 310 K in BL21 (DE3)-pLysS using
2YT]. The results for standard amounts spotted for referencing are shown
alongside (left column from top to bottom, 2000, 1500, 1000, 900, 800, 700,
600 and 500 ng per dot; right column from top to bottom, 400, 300, 200,
100, 50, 25, 12.5 and 0 ng per dot). The quantification is performed
automatically with the microplate reader implemented on the Tecan
robot (photon, calibration curve). Molecular-weight markers in kDa are
indicated.
between laboratories did not reveal any convincing relation-
ships. Analysis of variance indicated that both site (k) and
target (j) contributed significant variance to BESTj,k (p < 0.05),
but it was not possible to split the results into coherent
groupings. Where a consensus was seen (42% of the targets),
the target generally either expressed well (BEST = 3) or not at
all (BEST = 0). However, for a substantial number of the
targets the result reported was dependent on the parameters
explored by the small-scale screen. These parameters are
considered in more detail below.
3.3. Comparison of screen parameters
The number of parameters tested in the primary screen
varied considerably between groups. For example, Strasbourg
reported the results from a single condition, whereas Marseille
sampled three different variables (strain, medium and
temperature) in an incomplete factorial approach where 12
conditions derived from a sparse matrix covering 36 combi-
nations are used (adapted from Abergel et al., 2003). Most
groups varied temperature and used at least two expression
strains. The detection methods were more standard with
groups using SDS–PAGE and/or dot-blot analyses.
3.3.1. Aeration/media. Berlin reported expression
(BEST > 0) for the largest number of targets. The distinctive
feature of their protocol was very high-speed agitation of the
1 ml culture in 96-deep-well growth plates to ensure good
aeration (1200 rev min1 with a 2 mm orbit), carried out with
an enriched and buffered media (TB/SB+KPB, see supple-
mentary material and Scheich et al., 2003), which was also used
by Marseille and Oxford. The Marseille group (Vincentelli et
al., 2003) observed that whatever the medium used, the
number of hits for a given strain at a given temperature were
comparable, suggesting that the media were not a major
determinant of protein expression/solubility. The enhanced
expression achieved by Berlin using high aeration is note-
worthy, but may not be predictive of expression levels
attainable in standard shaker-flask-based scale-up protocols.
3.3.2. Culture temperature. The Berlin results also point to
the culture temperature following IPTG induction affecting
the production of soluble protein. The overall sum of soluble
expression scores (TOT_LABBerlin) was 64 for proteins
expressed at 310 K compared with 119 at 293 K (BEST > 0 for
27 and 50 targets at 310 and 293 K, respectively). The
Marseille group observed similar behaviour where (for a given
strain) the number of soluble expression hits was greater at
298 K compared with 310 K, while the number of hits was not
increased by further lowering the temperature to 290 K
(Fig. 3). This confirms the conventional wisdom that lower
temperatures tend to be more effective, reflected in the
protocols of several SPINE laboratories which routinely use a
single lower temperature (e.g. 293 K used by Oxford and
Strasbourg).
3.3.3. E. coli strains. Most groups screened for soluble
expression in at least two E. coli strains, with six of the eight
centres using a strain that co-expressed rare codons. The
sparse-matrix screen carried out by the Marseille group
comprised 12 different culture conditions for each of the 96
constructs, varying not only the post-
induction temperature but also the E.
coli strain (Vincentelli et al., 2005). The
results (Fig. 3) show the benefit of this
approach. Any one strain/temperature
combination gave, on average, a
TOT_LAB score of 58 (BEST > 0 for 30
targets), whereas using four strains at
three temperatures gave an aggregate
TOT_LAB of 114 (BEST > 0 for 49
targets). The different strain/tempera-
ture combinations can be ranked with
Rosetta (DE3)-pLysS/298 K and
Rosetta (DE3)-pLysS/310 K performing
best, giving 76 and 72 soluble proteins,
respectively. This suggests that for this
test set, containing mostly plasmids
encoding eukaryotic proteins, the use of
a codon-enhanced strain (e.g. strains
carrying the pLysSRARE plasmid) has
a greater positive contribution than the
culture temperature. This is in line with
the data from the Berlin group
(TOT_LABBerlin = 119, BEST > 0 for 50
targets), where the Rosetta (DE3)
strain was used at 293 K and the benefit
of using such strains for the expression
of eukaryotic proteins has been
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Figure 2
Plot of soluble expression results. The best soluble expression score for each target from each
SPINE group (BESTj,k) is presented as a three-dimensional plot. The targets (x axis) have been
ranked according to soluble expression score (y axis) from highest to lowest TOT_TARGETk and
the groups (z axis) ranked by laboratory score from highest to lowest TOT_LABj.
reported previously (Sorensen & Mortensen, 2005). It is
interesting to note, however, that the Marseille screening
procedure led to a gain of 19 additional soluble expression hits
from the full 12-condition screen.
3.3.4. Timing of induction. Induction is generally
performed at early or mid-log phase; however, there are
reports that induction in late-log phase (Galloway et al., 2003)
or even stationary phase (Ou et al., 2004) can influence both
total expression levels and solubility. To investigate this effect,
the Utrecht group (Folkers et al., 2004) performed induction at
early, mid- and late-log phase and at early stationary phase
corresponding to an OD600 of 0.8, 1.6, 2.3 and 3.0, respectively.
Overall, induction at early log phase gave the best results.
Stationary phase induction was counterproductive (total
expression was completely lost for half of the targets and
decreased for the remainder), while soluble expression was
reduced even more. In Utrecht 18 targets gave soluble
expression; for these, soluble expression of eight was not
influenced by more than a factor of two by the timing of
induction, whilst for five early induction was beneficial and for
five mid- or late-log gave the highest yields of soluble protein
(Fig. 4). Thus, the timing of induction may be a useful para-
meter to vary in small-scale expression screens.
3.3.5. Autoinduction. The auto-induction protocol of
Studier (2005) for pET-based T7 promoter vectors is amen-
able to high-throughput applications and a number of suitable
media preparations are available commercially. The Oxford
and Strasbourg protocols used auto-induction medium (alone
in Strasbourg and alongside IPTG induction in Oxford), but
the results from the two laboratories are surprisingly different
(TOT_LAB scores of 18 and 44, respectively, and BEST > 0
scores of 17 and 24). This discrepancy could reflect the shorter
growth time at lower temperature in Strasbourg (16 h at 293 K
versus 24 h at 298 K in Oxford) or differences in strains and
media. However, the strains used [BL21 (DE3) and B834
(DE3)] are closely related and the results presented above
suggest that the medium has relatively little effect on
expression/solubility, so it seems likely that time and
temperature account for much of the difference. The IPTG
and auto-induction results of Oxford (the use of both induc-
tion methods is standard in that laboratory) were similar
(SCALE = 12 and 14, respectively). Ten of these targets were
common to both induction regimes, with four targets detected
exclusively with auto-induction and two exclusively with
IPTG-induction. However, in general the previous experience
of both laboratories is that both IPTG and autoinduction
usually give qualitatively similar results, in terms of target
‘coverage’, although autoinduction can result in higher levels
of expression. Therefore, where soluble expression is detected
using both methods, auto-induction provides a simpler
procedure for scale-up, although the higher biomass obtained
using auto-induction may affect subsequent sample proces-
sing.
3.3.6. Control of expression. Strasbourg observed leaky
expression at the pre-culture stage for some targets that did
not give expression after overnight culture using auto-
inducible medium. This was probably a consequence of lactose
contamination in the media (Studier, 2004), which can be
eliminated by adding glucose to both pre-culture and culture
media. Alternatively, the BL21-AI strain (bearing a chromo-
somal copy of the T7 RNA polymerase gene under the control
of the arabinose-inducible araBAD promoter) provides a
tighter control of T7-based plasmids. For this target set, there
was no obvious advantage in using this strain since in the
hands of the Weizmann group only one target that failed in the
other groups gave soluble expression (see supplementary
material).
3.3.7. Detection method. The results allow us to compare
dot-blot (Stockholm and Marseille) and SDS–PAGE methods
for the detection of soluble expression. As shown in Figs. 1 and
2, no disagreement was found for the insoluble and highly
expressed constructs, but for the weakly expressed and/or
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Figure 3
Effect of E. coli strains, temperature at induction and media on protein
solubility. Summary of the results obtained by Marseille. The results of
the sparse-matrix screen for soluble expression of the benchmark vectors
are shown. The solubility level scores (0, 1, 2, 3) have been summed to
give a total value for each strain/post-induction growth temperature/
media combination and are indicated at the top of each bar.
Figure 4
Influence of culture conditions on soluble protein production: OD600.
Plasmids were transformed in RosettaII (DE3) strain and induced during
early (E), mid (M) or late (L) logarithmic growth phase or during early
stationary phase (S) using 1 mM IPTG for 14 h at 293 K. Extracts
prepared with PopCulture were affinity-purified using MagnaHis beads
and analyzed by SDS–PAGE. Examples are shown where the OD600
value influences soluble expression.
soluble there were large differences. The Stockholm dot-blot
protocol used comparable amounts of cell lysate to the SDS–
PAGE protocol of Oxford and Utrecht, but detected fewer
expressed clones. In contrast, Marseille, by loading five times
more purified protein, detected more soluble expressed
protein from the panel of clones; indeed, not every clone with
a positive dot-blot signal gave a detectable signal on SDS–
PAGE. It therefore seems that by loading more protein it is
possible to render the dot-blot method as sensitive as the
routine SDS–PAGE method. Dot-blots are eminently suitable
for automation; however, the lack of information about size
and purity is a serious limitation. For instance, the Stockholm
group picked up an erroneous, albeit weak, signal for one of
three known negatives in this test using a dot-blot screen. Dot-
blots are therefore best suited for initial screening in situations
where the success rate is expected to be very low (such as the
massively parallel analysis of constructs of proteins which are
very difficult to express).
4. Conclusions
During the course of the SPINE contract, a number of partner
laboratories have established rapid and cost-effective small-
scale screening for soluble expression in E. coli. In conjunction
with the parallel developments in upstream and downstream
technologies, these have fundamentally changed the sample-
preparation stages of structural biology. Our analysis of the
SPINE expression-screening pipelines demonstrates that the
different methodologies identify similar groups of best and
worst expressing proteins which can give, in most cases, a good
prediction of levels of soluble expression potentially attain-
able on scale-up. This is important since it enables effort
downstream of cloning and expression screening to be
invested in the most tractable targets. This study also high-
lighted the variability between protocols to detect proteins
that fell between the two extreme scores, demonstrating that,
at least for the anonymous often problematic targets chosen
for this study (mainly eukaryotic and viral proteins), there is a
substantial cohort for which the parameters chosen for the
screening have a major effect on the expression. This suggests
that the expression experiment has features in common with
other crystallographic activities such as crystallization, which
are conducted in a multi-parameter space. The present results
do not allow us to dissect fully the correlations that may exist
between the parameters in ‘expression space’, mainly because
the difficult nature of targets led to a rather low success rate.
Nevertheless, the effects of several parameters can be clearly
discerned (as discussed above) and we would suggest that the
‘sparse-matrix’ approach of Marseille, whilst expensive in
terms of the number of tests required per protein, could be
augmented and refined in the light of these findings. Further
work would then be required to establish sets of guidelines for
the most effective strategy for the production, for a particular
protein, of sufficient material for structural studies. The
components of this strategy would include (i) construct opti-
mization (discussed in Alzari et al., 2006, with library based-
methods to scan for expressible domains), (ii) the use of
homologous proteins from different species (see Siebold et al.,
2005), and (iii) the exploration of expression space, including
the optimized prokaryotic screening discussed here, but also,
especially if the proteins are particularly complex or subject to
post-translational modifications, screening in eukaryotic
expression systems (see, for example, Aricescu et al., 2006).
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